Stephen MacMillan, the former Stryker (NYSE:SYK) CEO whose abrupt departure stunned the orthopedics world earlier this year, did his level best to clear a romantic relationship with the company’s board but was ousted anyway, according to the Wall Street Journal.
Deerfield Management
Deerfield Management, Flynn sell more NeuroMetrix stock
Deerfield Management and general partner James Flynn continued to pare their stakes in NeuroMetrix Inc. (NSDQ:NURO).
The latest sell-off of nearly 332,000 shares, for an average of less than 51 cents, generated $169,000 for Flynn and the hedge fund, leaving a mere 782,000 NURO shares in their hands, according to regulatory filings.